Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Takashi, Shiroto"'
Age‐stratified profiles and outcomes of patients with heart failure with preserved ejection fraction
Autor:
Shinsuke Yamanaka, Kotaro Nochioka, Hideka Hayashi, Takashi Shiroto, Jun Takahashi, Satoshi Miyata, Satoshi Yasuda, Hiroaki Shimokawa, the CHART‐2 Investigators
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2223-2233 (2024)
Abstract Aims This study aimed to elucidate age‐stratified clinical profiles and outcomes in patients with heart failure (HF) with preserved left ventricular ejection fraction (LVEF) (HFpEF). Methods and results The Chronic Heart Failure Registry a
Externí odkaz:
https://doaj.org/article/8e0afca0760548f0a43f2ae666f4d2ad
Autor:
Kenji Nakano, Kotaro Nochioka, Satoshi Yasuda, Daito Tamori, Takashi Shiroto, Yudai Sato, Eichi Takaya, Satoshi Miyata, Eiryo Kawakami, Tetsuo Ishikawa, Takuya Ueda, Hiroaki Shimokawa
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1597-1604 (2023)
Abstract Aims Current approaches to classify chronic heart failure (HF) subpopulations may be limited due to the diversity of pathophysiology and co‐morbidities in chronic HF. We aimed to elucidate the clusters of chronic patients with HF by data
Externí odkaz:
https://doaj.org/article/dc22020d47644ba383f2dc5e0c81f81c
Autor:
Takahide Fujihashi, Kotaro Nochioka, Satoshi Yasuda, Yasuhiko Sakata, Hideka Hayashi, Takashi Shiroto, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 50, Iss , Pp 101345- (2024)
Background: In patients with chronic heart failure (CHF), comorbidities are often managed with multiple medications, characterized by polypharmacy, leading to increased risk of potentially inappropriate medication and adverse effects. Methods: We stu
Externí odkaz:
https://doaj.org/article/f4f5761d72b34fe9940499f3dc9bca3e
Autor:
Kotaro Nochioka, Takashi Shiroto, Hideka Hayashi, Takumi Inoue, Kazuma Oyama, Kai Susukita, Hiroyuki Takahama, Jun Takahashi, Hiroaki Shimokawa, Satoshi Yasuda
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 49, Iss , Pp 101277- (2023)
Background: Limited data exist on the prognostic significance of a history of cancer and atrial fibrillation (AF) in patients with coronary artery disease (CAD). This study aimed to evaluate the associations among a history of cancer, AF, and long-te
Externí odkaz:
https://doaj.org/article/118046b1aa164ba6a00fc06a3ff6019f
Autor:
Kotaro Nochioka, Shintaro Kato, Giampaolo Pileggi, Katsunori Horii, Takashi Shiroto, Hiroaki Shimokawa, Satoshi Yasuda
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 48, Iss , Pp 101273- (2023)
Externí odkaz:
https://doaj.org/article/433e928d9964461d93f7d369b441baaf
Autor:
Kotaro Nochioka, Satoshi Yasuda, Yasuhiko Sakata, Takashi Shiroto, Hideka Hayashi, Jun Takahashi, Hiroyuki Takahama, Satoshi Miyata, Hiroaki Shimokawa
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2445-2454 (2022)
Abstract Aims This study aimed to examine the prognostic significance of a history of cancer and atrial fibrillation (AF) in antithrombotic therapy for patients with chronic heart failure (CHF). Methods and results We enrolled consecutive 4876 CHF pa
Externí odkaz:
https://doaj.org/article/8129a8a1f23e434b8cadc00f2188fe8c
Publikováno v:
European Cardiology Review, Vol 18, Iss , Pp - (2023)
Professor Maseri pioneered the research and treatment of coronary vasomotion abnormalities represented by coronary vasospasm and coronary microvascular dysfunction (CMD). These mechanisms can cause myocardial ischaemia even in the absence of obstruct
Externí odkaz:
https://doaj.org/article/10b13b92e5c9497d8029d5f96e138f42
Autor:
Tomohiko Shindo, Kenta Ito, Tsuyoshi Ogata, Ryo Kurosawa, Kumiko Eguchi, Yuta Kagaya, Kenichiro Hanawa, Yuhi Hasebe, Kensuke Nishimiya, Takashi Shiroto, Jun Takahashi, Yasuo Okumura, Teruo Noguchi, Yukio Ozaki, Hiroyuki Daida, Nobuhisa Hagiwara, Tohru Masuyama, Taishiro Chikamori, Yoshihiro Fukumoto, Kenichi Tsujita, Hiroshi Kanai, Satoshi Yasuda, Hiroaki Shimokawa
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287714 (2023)
BackgroundDespite the advances in the treatment of cardiovascular diseases, effective treatment remains to be established to improve the quality of life and prognosis of patients with chronic coronary syndromes. This study was aimed to evaluate the e
Externí odkaz:
https://doaj.org/article/b72e0e04ce6e444490b791ccf80ade9a
Autor:
Kiyotaka Hao, Jun Takahashi, Koichi Sato, Akira Suda, Tomohiko Sindo, Shigeo Godo, Kensuke Nishimiya, Yoku Kikuchi, Takashi Shiroto, Satoshi Yasuda
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 43, Iss , Pp 101116- (2022)
Background: Due to the coronavirus disease 2019 (COVID-19) pandemic, the first state of emergency had been declared from April 7 to May 25, 2020, in Japan. This pandemic might affect the management for patients with acute myocardial infarction (AMI).
Externí odkaz:
https://doaj.org/article/515abcb4006e4f72af15115fa5e2871a
Autor:
Takahide Fujihashi, Yasuhiko Sakata, Kotaro Nochioka, Masanobu Miura, Ruri Abe, Shintaro Kasahara, Masayuki Sato, Hajime Aoyanagi, Shinsuke Yamanaka, Hideka Hayashi, Takashi Shiroto, Koichiro Sugimura, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa, CHART‐2 Investigators
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1027-1038 (2021)
Abstract Aims Prognostic impacts of serum uric acid (UA) levels in patients with chronic heart failure (CHF) remain inconclusive, especially for the whole range of serum UA levels. Methods and results In the Chronic Heart Failure Registry and Analysi
Externí odkaz:
https://doaj.org/article/9288cdef20f04080bb310720f7e47d14